The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis

被引:165
作者
Kim, H
Muller, WJ [1 ]
机构
[1] McMaster Univ, Inst Mol Biol & Biotechnol, Hamilton, ON L8S 4K1, Canada
[2] McMaster Univ, Dept Med Sci, Hamilton, ON L8S 4K1, Canada
[3] McMaster Univ, Dept Pathol, Hamilton, ON L8S 4K1, Canada
基金
英国医学研究理事会;
关键词
transgenic; epidermal growth factor receptor; erbB2; neu; mammary; tumorigenesis;
D O I
10.1006/excr.1999.4706
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A number of receptor systems have been implicated to play an important role in the development and progression of many human cancers. The epidermal growth factor (EGF) receptor tyrosine kinase family has been found to consistently play a leading role in tumor progression Indeed, in human breast cancer cases the prognosis of a patient is inversely correlated with the overexpression and/or amplification of this receptor family. Furthermore, downstream signaling components such as the Src kinases, PI3'K, and the Ras pathway display evidence of deregulation that can accelerate tumor progression. The transgenic mouse system has been ideal in elucidating the biological significance of this receptor family in mammary tumorigenesis. Molecular events involved in mammary tumorigenesis such as ligand binding, receptor dimerization, and the activation of downstream pathways have been addressed using this system. Although there are many molecular steps that appear to drive each stage of tumor development, the EGF receptor family appears to play a causal role in the progression to a transformed phenotype. (C) 1999 Academic Press.
引用
收藏
页码:78 / 87
页数:10
相关论文
共 115 条
[1]  
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[2]   Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes [J].
Amundadottir, LT ;
Leder, P .
ONCOGENE, 1998, 16 (06) :737-746
[3]  
Amundadottir LT, 1996, ONCOGENE, V13, P757
[4]   neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer [J].
Andrulis, IL ;
Bull, SB ;
Blackstein, ME ;
Sutherland, D ;
Mak, C ;
Sidlofsky, S ;
Pritzker, KPH ;
Hartwick, RW ;
Hanna, W ;
Lickley, L ;
Wilkinson, R ;
Qizilbash, A ;
Ambus, U ;
Lipa, M ;
Weizel, H ;
Katz, A ;
Baida, M ;
Mariz, S ;
Stoik, G ;
Dacamara, P ;
Strongitharm, D ;
Geddie, W ;
McCready, D .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1340-1349
[5]   The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology [J].
Arteaga, CL ;
Dugger, TC ;
Hurd, SD .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 38 (01) :49-56
[6]   c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function [J].
Biscardi, JS ;
Maa, MC ;
Tice, DA ;
Cox, ME ;
Leu, TH ;
Parsons, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :8335-8343
[7]   STOCHASTIC APPEARANCE OF MAMMARY-TUMORS IN TRANSGENIC MICE CARRYING THE MMTV/C-NEU ONCOGENE [J].
BOUCHARD, L ;
LAMARRE, L ;
TREMBLAY, PJ ;
JOLICOEUR, P .
CELL, 1989, 57 (06) :931-936
[8]   Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis [J].
Burden, S ;
Yarden, Y .
NEURON, 1997, 18 (06) :847-855
[9]  
CALLAHAN R, 1992, CANCER, V69, P1582, DOI 10.1002/1097-0142(19920315)69:6+<1582::AID-CNCR2820691313>3.0.CO
[10]  
2-Y